|
26 |
Oncotelic Announces Successful Completion of |
panda448 |
11/16/2021 9:27:46 AM |
|
25 |
Another TGF-beta acquisition- bode well for |
panda448 |
11/10/2021 5:47:11 PM |
|
24 |
$OTLC in immunotherapy space: Immunotherapy |
panda448 |
11/05/2021 7:56:33 PM |
|
23 |
ONCOTELIC ANNOUNCES UPDATE ON THE OT-101 CLINICAL |
panda448 |
10/22/2021 8:15:01 PM |
|
22 |
ONCOTELIC ACQUIRES FAST TO MARKET LATE-STAGE DRUG |
panda448 |
10/05/2021 6:19:24 PM |
|
21 |
OT-101 an antisense against TGF-2 for |
panda448 |
09/29/2021 8:17:18 PM |
|
20 |
ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE |
panda448 |
09/07/2021 6:46:29 PM |
|
19 |
PULMOHEAL/ ARTIVEDA IS CLINICALLY ACTIVE |
panda448 |
09/07/2021 6:45:04 PM |
|
18 |
ONCOTELIC AND GOLDEN MOUNTAIN PARTNERS FORMING A |
panda448 |
08/16/2021 7:04:07 PM |
|
16 |
ONCOTELIC CLOSES COVID-19 CLINICAL TRIAL EARLY |
CaptnAmerca |
06/15/2021 9:24:41 AM |
|
15 |
Mateon Therapeutics Inc. has changed its name to |
panda448 |
03/31/2021 3:24:28 PM |
|
14 |
Litchfield Hills upgrade price target to $4 from |
panda448 |
03/05/2021 2:04:49 PM |
|
13 |
MATEON THERAPEUTICS AND WINDLAS BIOTECH PUBLISH |
panda448 |
03/03/2021 8:41:37 PM |
|
12 |
MATEON PARTNERED WITH CHOPRA FOUNDATION ON |
panda448 |
02/16/2021 6:04:51 PM |
|
11 |
Targeting TGF-b pathway with COVID-19 Drug |
panda448 |
02/01/2021 6:05:26 PM |
|
10 |
MATEON LAUNCHING MOBILE APP, ARTIHEALTH, FOR |
panda448 |
01/26/2021 8:15:48 PM |
|
9 |
Zacks Small Cap Research: MATN: POSITIVE INTERIM |
panda448 |
01/14/2021 7:25:15 PM |
|
8 |
MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM |
panda448 |
01/13/2021 2:35:51 PM |
|
7 |
Litchfield Hills Research MATN-Buy-$3 PT: |
panda448 |
01/08/2021 1:53:46 PM |
|
6 |
We might need to redefine our approach to drug |
panda448 |
01/07/2021 7:02:27 PM |
|
5 |
MATEONS GLOBAL STUDY FOR OT-101/ TGF- |
panda448 |
12/30/2020 2:48:50 PM |
|
4 |
Initiating coverage of MATN, Buy rating and $3 |
panda448 |
12/15/2020 1:17:00 PM |
|
3 |
Positive early results in treating COVID-19: |
panda448 |
12/15/2020 1:13:54 PM |